Related Experiment Video

Updated: May 13, 2026

Purification of H3 and H4 Histone Proteins and the Quantification of Acetylated Histone Marks in Cells and Brain Tissue
09:43

Purification of H3 and H4 Histone Proteins and the Quantification of Acetylated Histone Marks in Cells and Brain Tissue

Published on: November 30, 2018

Histone deacetylases and cancer: causes and therapies

P Marks1, R A Rifkind, V M Richon

  • 1Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. paula_marks@mskcc.org

Nature Reviews. Cancer
|March 21, 2002
PubMed

Insights

Histone deacetylase (HDAC) inhibitors impact gene transcription, leading to cancer cell growth arrest, differentiation, and apoptosis. Understanding how these HDAC inhibitors work is key to their cancer therapy potential.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Histone acetyltransferases and histone deacetylases (HDACs) regulate histone acetylation.
  • Histone acetylation influences gene expression.
  • Altered gene transcription by HDAC inhibitors affects tumor cells.

Purpose of the Study:

  • To investigate the mechanism by which histone deacetylase (HDAC) inhibitors exert their anti-cancer effects.
  • To elucidate how HDAC inhibitors alter gene transcription in tumor cells.

Main Methods:

  • Analysis of gene transcription patterns.
  • Assessment of cellular responses (growth arrest, differentiation, apoptosis).

Main Results:

  • HDAC inhibitors alter the transcription of specific genes.
  • These transcriptional changes lead to significant anti-cancer effects.

Conclusions:

  • HDAC inhibitors represent a promising therapeutic strategy for cancer.
  • Further research is needed to fully understand the molecular mechanisms of HDAC inhibitors.

More Related Videos

Assays for Validating Histone Acetyltransferase Inhibitors09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

Unveiling Histone Proteoforms using 2D-TAU Gel Electrophoresis07:20

Unveiling Histone Proteoforms using 2D-TAU Gel Electrophoresis

Published on: October 18, 2024

Related Concept Videos

Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer is an enzyme that can...
Histone Variants at the Centromere02:30

Histone Variants at the Centromere

Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3 variants are also...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...